Quince Therapeutics, Inc. (QNCX)
0.1083
0.00 (0.00%)
USD |
NASDAQ |
Mar 05, 15:31
Quince Therapeutics Free Cash Flow : -38.98M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Recursion Pharmaceuticals, Inc. | -380.44M |
| Masimo Corp. | 193.10M |
| Ocular Therapeutix, Inc. | -216.89M |
| Gossamer Bio, Inc. | -158.51M |
| Ernexa Therapeutics, Inc. | -9.436M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -9.928M |
| Cash from Investing (Quarterly) | -1.781M |
| Cash from Financing (Quarterly) | 1.376M |
| Free Cash Flow Per Share (Quarterly) | -0.1854 |
| Free Cash Flow to Equity (Quarterly) | -10.51M |
| Free Cash Flow to Firm (Quarterly) | -10.00M |
| Free Cash Flow Yield | -763.9% |